Linked Data API

Show Search Form

Search Results

1063827
registered interest false more like this
date less than 2019-02-18more like thismore than 2019-02-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Breast Cancer: Nurses more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with secondary breast cancer have a dedicated nurse specialist allocated to them. more like this
tabling member constituency Oldham East and Saddleworth more like this
tabling member printed
Debbie Abrahams more like this
uin 222762 more like this
answer
answer
is ministerial correction false more like this
date of answer remove filter
answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
grouped question UIN 222763 more like this
question first answered
less than 2019-02-21T14:58:17.033Zmore like thismore than 2019-02-21T14:58:17.033Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4212
label Biography information for Debbie Abrahams remove filter
1063828
registered interest false more like this
date less than 2019-02-18more like thismore than 2019-02-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Breast Cancer more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, with reference to the statement on page 72 of the Independent Cancer Taskforce's Cancer Strategy for 2015-2020 that all NHS trusts should now be recording recurrent and secondary breast cancer patients, how many and what proportion of NHS trusts are undertaking such recording. more like this
tabling member constituency Oldham East and Saddleworth more like this
tabling member printed
Debbie Abrahams more like this
uin 222763 more like this
answer
answer
is ministerial correction false more like this
date of answer remove filter
answer text <p>The NHS Cancer Programme aims to improve access to cancer Clinical Nurse Specialists (CNS) for all cancer patients when they need it, including those with secondary breast cancer. Health Education England is also working to expand the number of CNS and develop clear CNS competencies and routes into training.</p><p>The National Cancer Registration and Analysis Service (NCRAS) has mandated collection of breast cancer recurrence data in its Cancer Services and Outcomes Dataset (COSD) since 2013. Hospital trusts are also required to submit recurrence data in the Cancer Waiting Times (CWT) dataset. Data published on the NCRAS legacy website shows that of the 140 trusts that could be expected to be collecting data on breast cancer recurrence in 2016, 140 submitted data for 2016 diagnoses through the COSD or CWT data collection mechanisms. The NCRAS legacy website is available at the following link:</p><p><a href="http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence" target="_blank">http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/recurrence</a></p>
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
grouped question UIN 222762 more like this
question first answered
less than 2019-02-21T14:58:17.227Zmore like thismore than 2019-02-21T14:58:17.227Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
4212
label Biography information for Debbie Abrahams remove filter